MRNA stock forecast
Our latest prediction for Moderna Inc's stock price was made on the Dec. 2, 2020 when the stock price was at 143.00$.
In the short term (2weeks), MRNA's stock price should underperform the market by -2.20%. During that period the price should oscillate between -12.11% and +13.63%.
In the medium term (3months), MRNA's stock price should underperform the market by -6.51%. During that period the price should oscillate between -36.53% and +23.44%.Get email alerts
Create a solid portfolio with MRNA
About Moderna Inc
Moderna is an American, Cambridge, Massachusetts-based biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA . The Moderna technology platform is to insert synthetic mRNA into living cells that would reprogram the cells to develop immune responses, rather than being created externally and injected as with conventional medicines. It is a novel technique abandoned by several large pharmaceutical and biotechnology companies that were unable to overcome the side effects of inserting RNA into cells. As of May 2020, no mRNA drug has been approved for human use.
At the moment the company generates 247M USD in revenues.
On its last earning announcement, the company reported a loss of -1.62$ per share.
The book value per share is 4.05$
Three months stock forecastDec. 2, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|